| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/01/2009 | EP1203025B1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and beta1 integrins |
| 07/01/2009 | CN101472613A Compositions comprising pyruvate alkyl esters and uses thereof |
| 07/01/2009 | CN101472489A Homogeneous dispersions containing citrus pulp and applications thereof |
| 07/01/2009 | CN101468205A Aqueous medicinal composition |
| 07/01/2009 | CN101468204A Eyedrops containing succinic acid chitosan |
| 07/01/2009 | CN101468203A Method for preparing cleavable polyethyleneglycol lipid derivates and application |
| 07/01/2009 | CN100506844C Novel peptides |
| 07/01/2009 | CN100506841C Method and carrier complexes for delivering molecules to cells |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506283C Plant substrates |
| 07/01/2009 | CN100506282C Linseed oil microcapsule powder and preparation method thereof |
| 07/01/2009 | CN100506281C Method and device for feeding living cells into a biological body fluid |
| 07/01/2009 | CN100506280C Uptake of macromolecules |
| 07/01/2009 | CN100506279C Method for preparing fat-soluble medicine nano micro particle |
| 07/01/2009 | CN100506278C Topical composition, topical composition precursor, and methods for manufacturing and using |
| 07/01/2009 | CN100506234C Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn disease |
| 06/30/2009 | US7553929 Administering nuclear factor kappa beta (nf-kb)peptide nuclear localization sequence to inhibit import of stress-responsive transcription factor; septic shock, skin disorders, autoimmune diseases |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553913 Comprised of ethylene oxide and one or more other alkylene oxide(s); superior properties for medical and surgical applications; biocompatibility, substantial non-toxicity, water solubility, desirable handling properties (e.g., hardness, ductility, malleability) |
| 06/30/2009 | US7553865 Compounded with glyceryl monostearate, sorbitan monostearate, or stearyl alcohol; excellent use feeling and excellent absorbability, causes no phase separation into an oil layer and an aqueous layer, stability |
| 06/30/2009 | US7553835 foam or mousse; antifungal such as ketoconazole, lower alcohol, fatty alcohol, a quaternary or ethoxylated sorbitan surfactant, water, hydrocarbon gas propellant; jock itch, tinea, dandruff and sebborheic dermatitis |
| 06/30/2009 | US7553830 Compositions for the delivery of negatively charged molecules |
| 06/30/2009 | US7553816 p-amidobenzylethers in drug delivery agents |
| 06/30/2009 | US7553810 Methods and compositions for sealing localized regions of damaged lung tissue to reduce overall lung volume, glue featuring an adhering moiety coupled to one or more other moieties including a cross-linkable moiety and/or one other adhering moiety; use in treating pulmonary conditions, emphysema, copd |
| 06/30/2009 | US7553656 Biologically pure bacterial cultures; alginate is produced in large amounts and with a certain determined content of mannuronate and guluronate residues; high yielding |
| 06/30/2009 | US7553641 Tumour necrosis factor binding ligands |
| 06/30/2009 | US7553500 6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol (laxofoxifene); a prodrug with a glidant, disintegrant, lubricant and diluent/filler in given amounts; unit dosage forms, including low dosage forms; selective estrogen receptor modulators |
| 06/30/2009 | US7553498 Gastrointestinal disorders; anitulcer agents; mixture with surfactants and distingrat; cellulose ether enteric coating |
| 06/30/2009 | US7553495 Liquid compositions comprising oxyalkylated polyglycerol esters |
| 06/30/2009 | US7553485 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof |
| 06/30/2009 | US7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof |
| 06/30/2009 | CA2459399C Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |
| 06/30/2009 | CA2422356C Suppository of retaining in lower region of rectum |
| 06/30/2009 | CA2407654C Liposome containing hydrophobic iodine compound |
| 06/30/2009 | CA2406833C Effervescent granules and methods for their preparation |
| 06/30/2009 | CA2387705C Stable pharmaceutical composition for oral use |
| 06/30/2009 | CA2373939C Generation of therapeutic microfoam |
| 06/30/2009 | CA2359874C Method for reducing hip joint laxity |
| 06/30/2009 | CA2359318C Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| 06/30/2009 | CA2236579C Methods and compositions for the delivery of monomeric proteins |
| 06/30/2009 | CA2203480C Interferon conjugates |
| 06/30/2009 | CA2198917C Sustained release of peptides from pharmaceutical compositions |
| 06/30/2009 | CA2158662C Sustained release veterinary composition |
| 06/25/2009 | WO2009079635A1 Interfering rna delivery system and uses thereof |
| 06/25/2009 | WO2009078804A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 06/25/2009 | WO2009078803A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 06/25/2009 | WO2009078802A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 06/25/2009 | WO2009078756A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 06/25/2009 | WO2009078755A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 06/25/2009 | WO2009078754A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 06/25/2009 | WO2009078447A1 Anti-norovirus agent, anti-influenza-virus agent, and anti-viral treatment method using each of the agents |
| 06/25/2009 | WO2009078445A1 Pharmaceutical preparation |
| 06/25/2009 | WO2009078366A1 α-LIPOIC ACID NANOPARTICLE AND METHOD FOR PRODUCING THE SAME |
| 06/25/2009 | WO2009077908A1 Colloidal particle comprising multivalent cyclic anions |
| 06/25/2009 | WO2009077769A2 Carrier |
| 06/25/2009 | WO2009077671A1 Solid inorganic/organic hybrid with modified surface |
| 06/25/2009 | WO2009077670A1 Organic/inorganic hybrid nanoparticulates made from iron carboxylates |
| 06/25/2009 | WO2009077599A2 Nanospheres with external surface of noble metal |
| 06/25/2009 | WO2009077592A1 Pharmaceutical dosage form comprising a liquid or flowable core composition |
| 06/25/2009 | WO2009077586A2 Methods and compositions for the preparation and use of toxin conjugates |
| 06/25/2009 | WO2009077438A1 Method for preparing protein conjugates |
| 06/25/2009 | WO2009077345A1 Transcutaneous pharmaceutical compositions containing a steroid hormone |
| 06/25/2009 | WO2009077154A1 Hydroxyalkyl starch derivatives and process for their preparation |
| 06/25/2009 | WO2009077153A1 Method for producing a hydroxyalkyl starch derivative with two linkers |
| 06/25/2009 | WO2009076764A1 Misuse preventative, controlled release formulation |
| 06/25/2009 | WO2009076742A1 Effervescent dietary composition for enhancing delivery of dietary ingredients |
| 06/25/2009 | WO2009053601A3 Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant |
| 06/25/2009 | WO2009047434A9 Use of carriers as preservatives and pharmaceutical composition containing same |
| 06/25/2009 | WO2009033039A9 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| 06/25/2009 | WO2008137826A3 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
| 06/25/2009 | US20090163844 Methods for the treatment or prevention of scars and/or keloids |
| 06/25/2009 | US20090163604 Process for Producing Tablet by High-Speed Direct Compression |
| 06/25/2009 | US20090163603 Sulfo-polymer powder and sulfo-polymer powder blends |
| 06/25/2009 | US20090163602 Silicone containing polymeric materials |
| 06/25/2009 | US20090163530 adapted to adhere to and dissolve in a mouth of a consumer include a water soluble film-forming polymer pullulan, antimicrobially effective amounts of essential oils thymol, methyl salicylate, eucalyptol and menthol; for killing plaque-producing germs that cause dental plaque, bad breath, gingivitis |
| 06/25/2009 | US20090163484 Pharmaceuticals containing fluoroquinolones |
| 06/25/2009 | US20090163449 Sulfo-polymer powder and sulfo-polymer powder blends with carriers and/or additives |
| 06/25/2009 | US20090163436 Methods for delivery of nucleic acids |
| 06/25/2009 | US20090163426 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery; contain cleavage sites specifically cleaved by prostate specific membrane antigen (PSMA); useful for substantially inhibiting the non-specific toxicity of a variety of therapeutic drugs |
| 06/25/2009 | US20090163419 Human growth hormone aqueous formulation |
| 06/25/2009 | US20090163408 Salicylanilides enhance oral delivery of therapeutic peptides |
| 06/25/2009 | US20090163405 Angiogenic peptides and uses thereof |
| 06/25/2009 | US20090163365 Water-swellable hybrid material with inorganic additives and method of Producing same |
| 06/25/2009 | US20090162441 Pulmonary delivery in treating disorders of the central nervous system |
| 06/25/2009 | US20090162440 Sodium alginate microsphere vascular embolus containing water-soluble drug and preparation and application thereof |
| 06/25/2009 | US20090162436 Compositions and methods for repair of tissues |
| 06/25/2009 | US20090162340 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 06/25/2009 | US20090162308 Use of 2,4'-dimethylpropiophenone as a fragrance substance |
| 06/25/2009 | US20090162295 Setting polymers based on polyester acrylates |
| 06/25/2009 | US20090162293 Methods and compositions for ultrasound imaging of apoptosis |
| 06/25/2009 | DE3943838B4 Kompositionen zur topischen Anwendung enthaltend Cyclosporine Compositions for topical application containing Cyclosporine |
| 06/25/2009 | CA2711961A1 Transcutaneous pharmaceutical compositions containing a steroid hormone |
| 06/25/2009 | CA2709268A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 06/25/2009 | CA2709267A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 06/25/2009 | CA2709266A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 06/25/2009 | CA2709259A1 Carrier |
| 06/25/2009 | CA2707980A1 Misuse preventative, controlled release formulation |
| 06/25/2009 | CA2707811A1 Hydroxyalkyl starch derivatives and process for their preparation |
| 06/25/2009 | CA2707806A1 Method for producing a hydroxyalkyl starch derivative with two linkers |
| 06/25/2009 | CA2707010A1 .alpha.-lipoic acid nanoparticles and methods for preparing thereof |